Mediators between body mass index and atrial fibrillation: a Mendelian Randomization study - Gao, Ziting; Xiao, Jun; Huang, Wuqing (medRxiv, 2023)
Background Although obesity is a recognized risk factor of atrial fibrillation (AF), the mechanisms are not fully understood. Thus, we aimed to identify the potential mediators between body mass index (BMI) and AF.Methods We conducted a two-sample Mendelian randomization (MR) analysis using publicly available summary-level data from genome-wide association studies. Univariable MR analyses were applied to identify potential mediators, and then the multivariable MR analyses were conducted to explore the mediated roles of circulating cytokines, metabolic markers and comorbidities in the association between BMI and AF.Results This MR study found a significant causal association between BMI and AF (OR=1.41, 95%CI=1.33-1.50; P<0.001), which was attenuated to 1.21 (95%CI=1.03-1.43) after being adjusted for leptin, in which 48.78% excess risk was mediated. After further adjustment for leptin and sleep apnoea or coronary heart disease, the association was attenuated to null (adjusted for leptin and sleep apnoea: OR=1.05, 95%CI=0.85-1.30; adjusted for leptin and coronary heart disease: OR=1.08, 95%CI=0.90-1.30), resulting in 87.80% and 80.49% excess risk being mediated, respectively.Conclusion These results identified an important mediated role of leptin, particularly for individuals with sleep apnoea or coronary heart disease, providing some clues for the underlying mechanisms behind the impact of obesity on AF risk.Funding Natural Science Foundation of Fujian Province (grant no. 2022J01706) and the Start-up Fund for high-level talents of Fujian Medical University (XRCZX2021026).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Natural Science Foundation of Fujian Province (grant no. 2022J01706) and the Start-up Fund for high-level talents of Fujian Medical University (XRCZX2021026) to Dr. Wuqing Huang. The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableAll raw data are available in the public repository IEU open gwas project (https://gwas.mrcieu.ac.uk/)AFAtrial fibrillationCRPC-reactive proteinBMIbody mass indexMRMendelian randomizationGWASsGenome-Wide Association StudiesLDL-Clow-density lipoprotein cholesterolHDL-Chigh-density lipoprotein cholesterolTCtotal cholesterolTGtriglyceridesGIANTGenetic Investigation of ANthropometric TraitsSNPssingle nucleotide polymorphismsIVW-MRinverse-variance weighted mendelian randomizationPERMpercentage of excess risk mediatedORodds ratio